PROPYLTHIOURACIL: 4-6 YEAR FOLLOW-UP OF SELECTED PATIENTS WITH GRAVES' DISEASE

Abstract
Sixty patients with Graves'' disease who had small to moderate sized diffuse goiters and hyperthyroidism were treated with propylthiouracil. Treatment was discontinued 4 or more yrs. prior to this study. In 40 (66.7%), the disease remains in remission.

This publication has 2 references indexed in Scilit: